These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23331224)

  • 1. Comparing the response rates for superiority, noninferiority and equivalence testing with multiple-to-one matched binary data.
    Tsong Y; Yuan M; Dong X; Wu YT; Shen M
    J Biopharm Stat; 2013; 23(1):98-109. PubMed ID: 23331224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalence and noninferiority testing in regression models and repeated-measures designs.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls.
    Fay MP; Huang CY; Twum-Danso NA
    Clin Trials; 2007; 4(6):598-610. PubMed ID: 18042569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of time-to-event data under a two-stage survival adaptive design in clinical trials.
    Lu Q; Tse SK; Chow SC
    J Biopharm Stat; 2010 Jul; 20(4):705-19. PubMed ID: 20496201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research.
    Ahn S; Park SH; Lee KH
    Radiology; 2013 May; 267(2):328-38. PubMed ID: 23610094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
    Xu J; Yu M
    Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A more powerful exact test of noninferiority from binary matched-pairs data.
    Lloyd CJ; Moldovan MV
    Stat Med; 2008 Aug; 27(18):3540-9. PubMed ID: 18314932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach to noninferiority testing: documented proof rather than arbitrary margins.
    Cleophas TJ; Zwinderman AH
    Am J Ther; 2012 Mar; 19(2):101-7. PubMed ID: 20975529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data.
    Julious SA; Campbell MJ
    Stat Med; 2012 Oct; 31(24):2904-36. PubMed ID: 22714646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision-theoretic views on simultaneous testing of superiority and noninferiority.
    Koyama T; Westfall PH
    J Biopharm Stat; 2005; 15(6):943-55. PubMed ID: 16279353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential tests for noninferiority and superiority.
    Brannath W; Bauer P; Maurer W; Posch M
    Biometrics; 2003 Mar; 59(1):106-14. PubMed ID: 12762447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials.
    Kong L; Kohberger RC; Koch GG
    J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of equivalence trials in showing the usefulness of treatments].
    Hermens ML; van Hout HP; Terluin B; Adèr HJ; de Haan M
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2162-6. PubMed ID: 14626832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninferiority hypotheses and choice of noninferiority margin.
    Ng TH
    Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.